Steve Pakola - Net Worth and Insider Trading

Steve Pakola Net Worth

The estimated net worth of Steve Pakola is at least $939,002 dollars as of 2024-11-05. Steve Pakola is the Chief Medical Officer of Regenxbio Inc and owns about 107,192 shares of Regenxbio Inc (RGNX) stock worth over $939,002. Details can be seen in Steve Pakola's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Steve Pakola has not made any transactions after 2024-03-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Steve Pakola

To

Steve Pakola Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Steve Pakola owns 3 companies in total, including Regenxbio Inc (RGNX) , Aerpio Pharmaceuticals Inc (ARPO) , and Aadi Bioscience Inc (AADI) .

Click here to see the complete history of Steve Pakola’s form 4 insider trades.

Insider Ownership Summary of Steve Pakola

Ticker Comapny Transaction Date Type of Owner
RGNX Regenxbio Inc 2024-03-05 Chief Medical Officer
ARPO Aerpio Pharmaceuticals Inc 2019-02-15 Chief Medical Officer
AADI Aadi Bioscience Inc 2017-03-15 Chief Medical Officer

Steve Pakola Latest Holdings Summary

Steve Pakola currently owns a total of 1 stock. Steve Pakola owns 107,192 shares of Regenxbio Inc (RGNX) as of March 5, 2024, with a value of $939,002.

Latest Holdings of Steve Pakola

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RGNX Regenxbio Inc 2024-03-05 107,192 8.76 939,002

Holding Weightings of Steve Pakola


Steve Pakola Form 4 Trading Tracker

According to the SEC Form 4 filings, Steve Pakola has made a total of 2 transactions in Regenxbio Inc (RGNX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Regenxbio Inc is the sale of 12,878 shares on March 5, 2024, which brought Steve Pakola around $365,220.

Insider Trading History of Steve Pakola

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Steve Pakola Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Steve Pakola Ownership Network

Ownership Network List of Steve Pakola

No Data

Ownership Network Relation of Steve Pakola

Insider Network Chart

Steve Pakola Owned Company Details

What does Regenxbio Inc do?

Who are the key executives at Regenxbio Inc?

Steve Pakola is the Chief Medical Officer of Regenxbio Inc. Other key executives at Regenxbio Inc include SVP of Technical Operations Curran Simpson , director & See Remarks Kenneth T. Mills , and See Remarks Vittal Vasista .

Regenxbio Inc (RGNX) Insider Trades Summary

Over the past 18 months, Steve Pakola made 1 insider transaction in Regenxbio Inc (RGNX) with a net sale of 12,878. Other recent insider transactions involving Regenxbio Inc (RGNX) include a net sale of 180,000 shares made by Kenneth T. Mills , a net sale of 51,100 shares made by Argeris N Karabelas , and a net sale of 9,748 shares made by Curran Simpson .

In summary, during the past 3 months, insiders sold 20,000 shares of Regenxbio Inc (RGNX) in total and bought 0 shares, with a net sale of 20,000 shares. During the past 18 months, 253,726 shares of Regenxbio Inc (RGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 253,726 shares.

Regenxbio Inc (RGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Regenxbio Inc Insider Transactions

No Available Data

Steve Pakola Mailing Address

Above is the net worth, insider trading, and ownership report for Steve Pakola. You might contact Steve Pakola via mailing address: C/o Regenxbio Inc., 9804 Medical Center Drive, Rockville Md 20850.